Lidokain Noridem

Lidocaine, the active ingredient in Lidokain Noridem, is a local anesthetic (amide) presented as a sterile solution for epidural, intradermal and intramuscular use. It provides reversible loss of sensation for minor surgical, diagnostic and pain‑control procedures in adult patients.

GNH USA supplies Lidokain Noridem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lidokain Noridem is a local anesthetic used to block nerve conduction in various clinical settings.

- Minor surgical or diagnostic procedures: provides reversible loss of sensation at the injection site. - Epidural analgesia: delivers analgesia during labor or postoperative pain management. - Intramuscular or intradermal infiltration for pain control: reduces localized pain in targeted tissues.

Lidokain Noridem may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Transient burning or stinging at the injection site - Mild dizziness - Nausea - Headache

Serious or Rare Side Effects: - Allergic reactions such as anaphylaxis or angioedema - Cardiac arrhythmias - Methemoglobinemia - Central nervous system toxicity, including seizures

When using Lidokain Noridem, several safety considerations should be observed.

- Allergy assessment: verify no known hypersensitivity to amide‑type local anesthetics. - Cardiovascular status: avoid in patients with severe heart block or conduction disorders. - Dosage limits: adhere to recommended maximum dose to prevent systemic toxicity. - Pregnancy and lactation: use only if the benefit outweighs the potential risk, as safety data are limited. - Store below 25°C: keep in the original container, protect from moisture and light.

Lidokain Noridem can interact with other medicines, requiring attention to avoid adverse effects.

Major Interactions (Avoid): - Class I antiarrhythmics (e.g., quinidine, procainamide): may increase lidocaine plasma levels and toxicity. - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): can reduce metabolism, raising risk of adverse effects.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may potentiate cardiovascular depression. - General anesthetics (e.g., propofol, volatile agents): additive central nervous system depression. - Diuretics (e.g., furosemide): may enhance lidocaine toxicity by reducing plasma protein binding.